Biotest AG

BTTAY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$26,400$127,000$31,700-$63,400
Dep. & Amort.$40,600$35,900$35,800$31,100
Deferred Tax$0$0-$1,000$0
Stock-Based Comp.$0$0$0$0
Change in WC-$200-$168,500-$45,200$21,500
Other Non-Cash-$5,900$2,900-$62,800$44,700
Operating Cash Flow$60,900-$2,700-$40,500$33,900
Investing Activities
PP&E Inv.-$28,700-$33,400-$29,300-$18,200
Net Acquisitions$0$35,000$0$300
Inv. Purchases$0$0-$7,800-$5,500
Inv. Sales/Matur.$0$0$0$5,200
Other Inv. Act.$3,000-$300$100-$5,200
Investing Cash Flow-$25,700$1,300-$37,000-$23,400
Financing Activities
Debt Repay.-$27,700-$1,900$100,000$25,100
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$1,600$0-$800-$800
Other Fin. Act.-$6,100-$4,900-$9,600-$1,700
Financing Cash Flow-$35,400-$6,800$89,600$22,600
Forex Effect-$100$100$100$0
Net Chg. in Cash-$300-$8,500$12,200$33,100
Supplemental Information
Beg. Cash$108,100$116,600$104,400$71,300
End Cash$107,800$108,100$116,600$104,400
Free Cash Flow$32,200-$36,100-$69,800$15,700